Sort by
Refine Your Search
-
Program
-
Field
-
and curious Postdoctoral Fellow to develop and drive projects on retinal disease modeling and repair. OPTI is a part of Genentech Research and Early Development (gRED): scientists in gRED
-
. This position offers a unique opportunity to be jointly mentored by experts in our Computational Biology and Medicine department and our Oncology Research organization. The Role: Primarily focused on tumor
-
fellowships positions to work on exciting research and drug discovery projects. While students can apply to our postdoc program by submitting applications to specific labs that have opened positions,https
-
access to state-of-the-art analytics and a robust cross-functional scientific community. The Opportunity: You will be part of the Genentech post-doctoral training program that provides an outstanding
-
the molecular pathways of disease and to establish the mechanism of action of our therapeutics. The successful candidate will work with our team to analyze multi-level biomarker data generated from pre-clinical
-
discovery. This position in particular focuses on sequence-to-function deep genomics modeling, with the goal of developing performant models that make generalizable out-of-distribution predictions
-
Fellow will lead projects that will advance our understanding on the role of distinct cellular states and tumor microenvironments in cancer, with a particular emphasis on metastatic breast cancer and tumor
-
motivated recent and pending PhD graduates to join us as Postdoctoral Fellows. Genentech’s Postdoctoral Program will give you the chance to work on fundamental biomedical research questions. With an emphasis
-
The Position We are seeking a talented and highly motivated Postdoctoral Fellow to become part of our dynamic team in the Computational Sciences Department (gCS) within Genentech's Research
-
on developing and applying foundational AI models to investigate clinically relevant cancer vulnerabilities and their relationship with molecular context. Spanning functional genomics and large-scale clinical